New susceptibility breakpoints in antimicrobial resistance rates of invasive pneumococcal strains

Jornal de Pediatria

Volumn 85, Issue 5, 2009, Pages 421-425

  Wolkers, Paula Carolina Bejo ^a   Mantese, Orlando Cesar ^a,b   De Paula, Alan ^a   Almeida, Vivieni Vieira Prado ^a,c   De Aguiar, Paula Augusta Dias Fogaça ^a   Alvares, Jackelline Rodrigues ^b,d   Almeida, Samanta Cristine Grassi ^b,d   Brandileone, Maria Cristina De Cunto ^b,d  

^a FEDERAL UNIVERSITY OF UBERLÂNDIA   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d INSTITUTO ADOLFO LUTZ   (Brazil)

Author keywords

Antimicrobial resistance; Pneumococcus; Pneumonia

Indexed keywords

CEFTRIAXONE; CHLORAMPHENICOL; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; OFLOXACIN; OXACILLIN; PENICILLIN G; TETRACYCLINE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL PNEUMONIA; BACTERIUM CULTURE; BLOOD SAMPLING; CHILD; FEMALE; HUMAN; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PENICILLIN RESISTANCE; PLEURA FLUID;

ADOLESCENT; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; MICROBIAL SENSITIVITY TESTS; PENICILLIN RESISTANCE; PENICILLINS; PLEURAL CAVITY; PNEUMONIA, PNEUMOCOCCAL; STREPTOCOCCUS PNEUMONIAE;

EID: 70350439501     PISSN: 00217557     EISSN: None     Source Type: Journal    
DOI: 10.2223/JPED.1931     Document Type: Article

References (26)

1. American Academy of Pediatrics. Pneumococcal infections. In: RED BOOK - Report of the Committee on Infectious Diseases. 27th ed. Illinois: Elk Grove Village; 2006. p.525-537
2. Fedson DS, Musher MM. Pneumococcal vaccine. In: Plotkin SA, Mortimer EA Jr., editors. Vaccines. 2ed. Philadelphia, PA: W B Saunders; 1994. p.517-564
3. Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network. Streptococcus pneumonia, 2007. http://www.cdc.gov/ncidod/ dbmd/abcs/survreports/spneu07.pdf. Access: 23/02/2009.
4. Shann F. The management of pneumonia in children in developing countries. Clin Infect Dis. 1995;21 Suppl 3:S218-25.
5. Bartlett JG, Dowell SF, Mandell LA, File Jr TM, Musher FM, Fine MJ. Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America. Clin Infect Dis. 2000;31:347-382
6. Heffelfinger JD, Dowell SF, Jorgensen JH, Klugman KP, Mabry LR, Musher DM, et al. Management of community-acquired pneumonia in the era of pneumococcal resistance: a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group. Arch Intern Med. 2000;160:1399-1408
7. Appelbaum PC. Epidemiology and in vitro susceptibility of drug-resistant Streptococcus pneumoniae. Pediatr Infect Dis J. 1996;15:932-934
8. Kaplan SL. Review of antibiotic resistance, antibiotic treatment and prevention of pneumococcal pneumonia. Pediatr Respir Rev. 2004;5 Suppl A:S153-8.
9. Okeke IN, Laxminarayan R, Bhutta ZA, Duse AG, Jenkins P, O'Brien TF, et al. Antimicrobial resistance in developing countries. Part I: recent trends and current status. Lancet Infect Dis. 2005;5:481-493
10. Organización Panamericana de la Salud. Informe Regional de SIREVA II: datos por país y por grupo de edad sobre las características de los aislamientos de Streptococcus pneumoniae, Haemophilus influenzae y Neisseria meningitidis em processos invasores, 2000-2005. Documentos Técnicos. Tecnologias Esenciales de Salud. THS/EV-2007/002. Washington, DC: OPS; 2007.
11. Organización Panamericana de la Salud. Informe Regional de SIREVA II, 2006: datos por país y por grupo de edad sobre las características de los aislamientos de Streptococcus pneumoniae, Haemophilus influenzae y Neisseria meningitidis em processos invasores. Documentos Técnicos. Tecnologias Esenciales de Salud. THS/EV-2008/001. Washington, DC: OPS; 2008.
12. Organización Panamericana de la Salud. Informe Regional de SIREVA II, 2007: datos por país y por grupo de edad sobre las características de los aislamientos de Streptococcus pneumoniae, Haemophilus influenzae y Neisseria meningitidis em processos invasores. Documentos Técnicos. Tecnologias Esenciales de Salud. THS/EV-2008/003. Washington, DC: OPS; 2008.
13. Di Fabio JL, Castaneda E, Agudelo CI, De La Hoz F, Hortal M, Camou T, et al. Evolution of Streptococcus pneumoniae serotypes and penicillin susceptibility in Latin America, Sireva-Vigia Group, 1993 to 1999. PAHO Sireva-Vigía Study Group. Pan American Health Organization. Pediatr Infect Dis J. 2001;20:959-967
14. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility tests: approved standard. NCCLS Publication M2-A5. Villanova, PA: NCCLS; 1997.
15. Clinical and Laboratory Standards Institute/NCCLS. Performance Standards for Antimicrobial Susceptibility Testing; Fifteenth Informational Supplement. CLSI/NCCLS document M100-S15. Wayne, PA: CLSI; 2005.
16. National Committee for Clinical Laboratory Standards. Supplemental Tables. Performance Standards for Antimicrobial Susceptibility Testing; Twelfth Informational Supplement. NCCLS Publication M100-S12, Vol.22, No.1. M2-A7 and M7-A5.Villanova, PA: NCCLS; 2002.
17. Brandileone MC, Vieira VS, Zanella RC, Landgraf IM, Melles CE, Taunay AE, et al. Distribution of serotypes of Streptococcus pneumoniae isolated from invasive infections over a 16-year period in the greater São Paulo area, Brazil. J Clin Microbiol. 1995;33:2789-2791
18. Brandileone MC, Vieira VS, Casagrande ST, Zanella RC, Guerra ML, Brandão AP, et al. Characteristics of isolates Streptococcus pneumoniae from middle aged and elderly adults in Brazil: capsular serotypes and antimicrobial sensitivity with invasive infections. Braz J Infect Dis. 1998;2:90-96
19. Kertesz DA, Di Fabio JL, de Cunto Brandileone MC, Castaneda E, Echaniz-Aviles G, Heitmann I, et al. Invasive Streptococcus pneumoniae infection in Latin American children: results of the Pan American Health Organization Surveillance Study. Clin Infect Dis. 1998;26:1355-1361 (Pubitemid 28270165)
20. Brandileone MC, de Andrade AL, Di Fabio JL, Guerra ML, Austrian R. Appropriateness of a pneumococcal conjugate vaccine in Brazil: potencial impact of age and clinical diagnosis, with emphasis on meningitis. J Infect Dis. 2003;187:1206-1212 (Pubitemid 36438960)
21. Nascimento-Carvalho CM, Freitas-Souza LS, Moreno-Carvalho OA, Alves NN, Caldas RM, Barberino MG, et al. Cepas invasivas de pneumococo isoladas de crianças e adolescentes em Salvador. J Pediatr (Rio J). 2003;79:209-214
22. Koeth LM, Felmingham D, Jacobs MR, Rossi F. Antimicrobial resistance of Streptococcus pneumoniae and Haemophilus influenzae in Sao Paulo, Brazil from 1996 to 2000. Int J Antimicrob Agents. 2004;23:356-361
23. Bedran MB, Camargos PA, Leocádio Filho G, Bedran RM, Najar HC. Susceptibility of Streptococcus pneumoniae to penicillin in the State of Minas Gerais, Brazil from 1997-2004. Braz J Infect Dis. 2005;9:390-397
24. Mantese OC, Paula A, Moraes AB, Moreira TA, Guerra ML, Brandileone MC. Prevalência de sorotipos e resistência antimicrobiana de cepas ibnvasivas do Streptococcus pneumoniae. J Pediatr (Rio J). 2003;79:537-542 (Pubitemid 38139237)
25. Cardoso MR, Nascimento-Carvalho CM, Ferrero F, Berezin EN, Ruvinsky R, Camargos PA, et al. Penicillin-resistant pneumococcus and risk of treatment failure in pneumonia. Arch Dis Child. 2008;93:221-225 (Pubitemid 352025494)
26. Hyde TB, Gay KV, Stephens DS, Vugia DJ, Pass M, Johnson S et al. Macrolide resistance among invasive Streptococcus pneumoniae isolates. JAMA, 2001;286:1857-1862 (Pubitemid 33010237)